| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.7M | — | — |
| Cost of Revenue | $3.3M | — | — |
| Gross Profit | $371K | — | — |
| R&D Expense | $274K | — | — |
| SG&A Expense | $3.5M | — | +134.1% |
| Operating Income | -$3.8M | — | -152.9% |
| Pre-tax Income | -$26.2M | — | -125.4% |
| Income Tax | $38K | — | — |
| Net Income | -$27.1M | — | -126.4% |
| EPS (Basic) | -$1.01 | — | -104.9% |
| EPS (Diluted) | -$1.14 | — | -106.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $6.4M | +144.8% | +44.1% |
| Short-term Investments | $120K | -52.0% | — |
| Accounts Receivable | $3.6M | +619.2% | — |
| Inventory | $3.5M | — | — |
| Current Assets | $22.8M | +68.3% | +169.5% |
| Total Assets | $315.5M | +55.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.9M | — | -267.3% |
| Capital Expenditures | $154K | — | +1406.7% |
| Investing Cash Flow | -$3.8M | — | -371.8% |
| Financing Cash Flow | $12.5M | — | — |
| Free Cash Flow | -$5.1M | — | -275.9% |
| +3567.7% |
| Current Liabilities | $91.6M | +110.4% | +41.6% |
| Long-term Debt | $3.1M | — | +96.8% |
| Total Liabilities | $98.4M | +117.8% | +49.5% |
| Stockholders' Equity | $36.2M | +282.8% | +163.2% |